KLI: 3-(5-benzyl-1,2,4-oxadiazol-3-yl)-6-fluoro-1-[2-fluoro-4-(trifluoromethyl)benzyl]-7-(4-methylpiperazin-1-yl)quinolin-4(1H)-one
KLI is a Ligand Of Interest in 3UDL designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3UDL_KLI_D_571 | 75% | 24% | 0.107 | 0.939 | 1.78 | 1.47 | 5 | 8 | 1 | 0 | 100% | 1 |
| 3UDL_KLI_C_571 | 69% | 25% | 0.115 | 0.929 | 1.74 | 1.44 | 5 | 9 | 0 | 0 | 100% | 1 |
| 3UDL_KLI_A_571 | 65% | 24% | 0.12 | 0.921 | 1.77 | 1.5 | 5 | 6 | 0 | 0 | 100% | 1 |
| 3UDL_KLI_B_571 | 64% | 24% | 0.125 | 0.923 | 1.81 | 1.46 | 5 | 7 | 1 | 0 | 100% | 1 |
